JPMorgan Chase & Co’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.93M | Sell |
|
|||||
|
2025
Q1 | $16.7M | Buy |
|
|||||
|
2024
Q4 | $10.8M | Buy |
|
|||||
|
2024
Q3 | $7.9M | Buy |
|
|||||
|
2024
Q2 | $4.82M | Sell |
|
|||||
|
2024
Q1 | $6.72M | Buy |
|
|||||
|
2023
Q4 | $4.51M | Buy |
|
|||||
|
2023
Q3 | $3.69M | Sell |
|
|||||
|
2023
Q2 | $4.26M | Sell |
|
|||||
|
2023
Q1 | $7.67M | Sell |
|
|||||
|
2022
Q4 | $8.66M | Buy |
|
|||||
|
2022
Q3 | $7.12M | Sell |
|
|||||
|
2022
Q2 | $7.32M | Buy |
|
|||||
|
2022
Q1 | $2.3M | Buy |
|
|||||
|
2021
Q4 | $1.75M | Buy |
|
|||||
|
2021
Q3 | $1.41M | Buy |
|
|||||
|
2021
Q2 | $1.61M | Buy |
|
|||||
|
2021
Q1 | $1.28M | Sell |
|
|||||
|
2020
Q4 | $1.75M | Buy |
|
|||||
|
2020
Q3 | $792K | Sell |
|
|||||
|
2020
Q2 | $1.05M | Buy |
|
|||||
|
2020
Q1 | $669K | Sell |
|
|||||
|
2019
Q4 | $946K | Buy |
|
|||||
|
2019
Q3 | $511K | Buy |
|
|||||
|
2019
Q2 | $524K | Buy |
|
|||||
|
2019
Q1 | $491K | Sell |
|
|||||
|
2018
Q4 | $1.72M | Sell |
|
|||||
|
2018
Q3 | $7.19M | Sell |
|
|||||
|
2018
Q2 | $11.9M | Sell |
|
|||||
|
2018
Q1 | $21.1M | Buy |
|
|||||
|
2017
Q4 | $6.92M | Buy |
|
|||||
|
2017
Q3 | $59K | Sell |
|
|||||
|
2017
Q2 | $2.22M | Sell |
|
|||||
|
2017
Q1 | $2.42M | Sell |
|
|||||
|
2016
Q4 | $2.36M | Buy |
|
|||||
|
2016
Q3 | $654K | Buy |
|
|||||
|
2016
Q2 | $2K | Sell |
|
|||||
|
2016
Q1 | $2.87M | Buy |
|
|||||
|
2015
Q4 | $2.53M | Buy |
|